Fully Human CD19-Targeted CAR T-Cell Therapy for Relapsed or Refractory Large B-Cell Lymphoma: Results of a First-in-Human Phase I/II Study
Nicolas Gazeau(Centre Hospitalier Universitaire de Lille), Jordan Gauthier(Seattle Cancer Care Alliance), David G. Maloney(Fred Hutch Cancer Center), Delaney R. Kirchmeier(Fred Hutch Cancer Center), Henna A Di(Fred Hutch Cancer Center), Brian G. Till(University of Washington), Alexandre V. Hirayama(University of Washington), Salvatore Fiorenza, Mazyar Shadman(University of Washington), Stanley R. Riddell(Fred Hutch Cancer Center), Cameron J. Turtle(The University of Sydney), Barbara S. Pender, Erik L. Kimble(University of Washington)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k